[go: up one dir, main page]

FI962445A0 - Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi - Google Patents

Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi

Info

Publication number
FI962445A0
FI962445A0 FI962445A FI962445A FI962445A0 FI 962445 A0 FI962445 A0 FI 962445A0 FI 962445 A FI962445 A FI 962445A FI 962445 A FI962445 A FI 962445A FI 962445 A0 FI962445 A0 FI 962445A0
Authority
FI
Finland
Prior art keywords
preparation
paroxetine tablets
paroxetine
tablets
Prior art date
Application number
FI962445A
Other languages
English (en)
Swedish (sv)
Other versions
FI962445A (fi
Inventor
Ram Dutta Pathak
David George Doughty
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10746644&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI962445(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of FI962445A0 publication Critical patent/FI962445A0/fi
Publication of FI962445A publication Critical patent/FI962445A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI962445A 1993-12-15 1996-06-12 Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi FI962445A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939325644A GB9325644D0 (en) 1993-12-15 1993-12-15 Novel formulation
PCT/EP1994/004164 WO1995016448A1 (en) 1993-12-15 1994-12-14 Paroxetine tablets and process to prepare them

Publications (2)

Publication Number Publication Date
FI962445A0 true FI962445A0 (fi) 1996-06-12
FI962445A FI962445A (fi) 1996-06-12

Family

ID=10746644

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962445A FI962445A (fi) 1993-12-15 1996-06-12 Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi

Country Status (36)

Country Link
US (1) US6113944A (fi)
EP (1) EP0734260B2 (fi)
JP (1) JP3037757B2 (fi)
KR (1) KR100367796B1 (fi)
CN (1) CN1071116C (fi)
AP (1) AP540A (fi)
AT (1) ATE180973T1 (fi)
AU (1) AU697982B2 (fi)
BG (1) BG62755B1 (fi)
BR (1) BR9408219A (fi)
CA (4) CA2214575C (fi)
CZ (1) CZ287891B6 (fi)
DE (1) DE69419033T2 (fi)
DK (1) DK0734260T4 (fi)
DZ (1) DZ1835A1 (fi)
ES (1) ES2132610T5 (fi)
FI (1) FI962445A (fi)
GB (1) GB9325644D0 (fi)
GR (1) GR3031047T3 (fi)
HK (1) HK1012285A1 (fi)
HU (1) HUT75880A (fi)
IL (1) IL111978A (fi)
MA (1) MA23395A1 (fi)
MY (1) MY112123A (fi)
NO (1) NO307366B1 (fi)
NZ (1) NZ277790A (fi)
OA (1) OA10297A (fi)
PL (1) PL314980A1 (fi)
RO (1) RO115413B1 (fi)
RU (1) RU2146141C1 (fi)
SA (1) SA94150373B1 (fi)
SI (1) SI0734260T2 (fi)
SK (1) SK282620B6 (fi)
UA (1) UA42745C2 (fi)
WO (1) WO1995016448A1 (fi)
ZA (1) ZA949900B (fi)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086053A1 (en) * 1993-12-15 2002-07-04 Smithkline Beecham Plc Formulations, tablets of paroxetine and process to prepare them
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
US6548084B2 (en) 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method
US6638948B1 (en) * 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
ATE200781T1 (de) 1997-06-10 2001-05-15 Synthon Bv 4-phenylpiperidin-derivate
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
US6699882B2 (en) 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
US6168805B1 (en) * 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
GB9810181D0 (en) * 1998-05-13 1998-07-08 Smithkline Beecham Plc Novel formulations
DE19821625C1 (de) * 1998-05-15 2000-01-05 Merck Patent Gmbh Pharmazeutische Zubereitung
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
WO2000078290A2 (en) * 1999-06-22 2000-12-28 Smithkline Beecham P.L.C. Pharmaceutical composition comprising a salt of paroxetine
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
NZ523902A (en) * 2000-08-28 2004-05-28 Synthon Bv Paroxetine compositions and processes for making the same
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
AR034898A1 (es) 2001-07-31 2004-03-24 Lundbeck & Co As H Composicion cristalina que contiene escitalopram
HUP0401895A2 (hu) * 2001-10-22 2004-12-28 Synthon B.V. Paroxetin N-formil származékai, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
CA2471715A1 (en) * 2001-12-28 2003-07-17 Teva Pharmaceutical Industries Ltd. A stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
US20080032959A1 (en) * 2004-06-23 2008-02-07 Alves Stephen E Estrogen Receptor Modulators
US20060063737A1 (en) * 2004-08-18 2006-03-23 Holmdahl Lisa K Liquid paroxetine compositions
WO2006023347A1 (en) * 2004-08-20 2006-03-02 Alpharma, Inc. Paroxetine formulations
US20060216345A1 (en) * 2005-03-24 2006-09-28 Sun Pharmaceutical Industries Limited Oral pharmaceutical composition including paroxetine
AU2006315684A1 (en) * 2005-11-14 2007-05-24 Auspex Pharmaceuticals, Inc. Substituted phenylpiperidines with serotoninergic activity and enhanced therapeutic properties
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US9138430B2 (en) * 2007-12-27 2015-09-22 Mylan Specialty L.P. Formulation and method for the release of paroxetine in the large intestine
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
CN109771381B (zh) * 2017-11-13 2021-02-19 北京福元医药股份有限公司 一种帕罗西汀药物制剂

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50116401A (fi) * 1974-03-04 1975-09-11
ZA813205B (en) * 1980-12-05 1983-03-30 Smith Kline French Lab Dosage units
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
GB8520154D0 (en) * 1985-08-10 1985-09-18 Beecham Group Plc Chemical process
EP0223334B1 (en) * 1985-08-10 1991-07-10 Beecham Group Plc Process for the preparation of aryl-piperidine carbinols
DE3688827T2 (de) * 1985-10-25 1994-03-31 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel.
GB8626936D0 (en) * 1986-11-11 1986-12-10 Ferrosan As Treatment
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
EP0558679A1 (en) * 1990-11-24 1993-09-08 BEECHAM GROUP plc Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
GB9209687D0 (en) * 1992-05-06 1992-06-17 Smithkline Beecham Plc Novel process
US5776969A (en) * 1997-02-27 1998-07-07 Eli Lilly And Company Treatment of sleep disorders

Also Published As

Publication number Publication date
CA2274387A1 (en) 1995-06-22
SA94150373A (ar) 2005-12-03
AU1314595A (en) 1995-07-03
NO307366B1 (no) 2000-03-27
BR9408219A (pt) 1997-08-26
GR3031047T3 (en) 1999-12-31
CN1071116C (zh) 2001-09-19
DE69419033T2 (de) 1999-11-25
CN1137236A (zh) 1996-12-04
ZA949900B (en) 1995-10-10
GB9325644D0 (en) 1994-02-16
RO115413B1 (ro) 2000-02-28
CA2214575C (en) 1999-12-07
HU9601665D0 (en) 1996-08-28
CA2178637C (en) 1997-12-23
KR100367796B1 (ko) 2003-07-22
CZ287891B6 (cs) 2001-03-14
IL111978A0 (en) 1995-03-15
IL111978A (en) 2000-07-16
ES2132610T5 (es) 2008-12-16
CA2214575A1 (en) 1995-06-22
AU697982B2 (en) 1998-10-22
EP0734260B2 (en) 2008-07-09
DK0734260T3 (da) 1999-11-15
MY112123A (en) 2001-04-30
JPH09506602A (ja) 1997-06-30
NZ277790A (en) 1998-02-26
CZ176396A3 (en) 1996-09-11
DE69419033D1 (de) 1999-07-15
DK0734260T4 (da) 2008-09-29
AP540A (en) 1996-09-20
FI962445A (fi) 1996-06-12
SI0734260T1 (en) 1999-08-31
JP3037757B2 (ja) 2000-05-08
SI0734260T2 (sl) 2008-12-31
OA10297A (en) 1997-10-07
SK75696A3 (en) 1996-11-06
BG100648A (bg) 1997-02-28
CA2274389A1 (en) 1995-06-22
CA2178637A1 (en) 1995-06-22
ATE180973T1 (de) 1999-06-15
UA42745C2 (uk) 2001-11-15
RU2146141C1 (ru) 2000-03-10
MA23395A1 (fr) 1995-07-01
HUT75880A (en) 1997-05-28
EP0734260B1 (en) 1999-06-09
EP0734260A1 (en) 1996-10-02
US6113944A (en) 2000-09-05
PL314980A1 (en) 1996-09-30
SK282620B6 (sk) 2002-10-08
BG62755B1 (bg) 2000-07-31
NO962547D0 (no) 1996-06-14
AP9400704A0 (en) 1995-01-31
HK1012285A1 (en) 1999-07-30
SA94150373B1 (ar) 2006-05-27
CA2274389C (en) 2004-09-14
NO962547L (no) 1996-06-14
DZ1835A1 (fr) 2002-02-17
WO1995016448A1 (en) 1995-06-22
ES2132610T3 (es) 1999-08-16

Similar Documents

Publication Publication Date Title
FI962445A0 (fi) Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi
FI941137A (fi) 2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi
EE9500064A (et) Asendatud 1H-imidasoolid, nende valmistamismeetodid ja farmatseutilised kompositsioonid
FI961599A (fi) 1N-alkyyli-N-aryylipyrimidiiniamiineja ja niiden johdannaisia
FI944832A (fi) Farmaseuttinen koostumus
BR9407089A (pt) Moega e método
PL305288A1 (en) Novel piperidine derivatives, method of obtaining them and pharmaceutical agent
NO970293D0 (no) Substituerte camptotecinderivater og fremgangsmåte for dens fremstilling
FI950596A0 (fi) Polymeerinen alumiinisilikaattisulfaatti ja menetelmä ja laitteisto sen valmistamiseksi
FI942932A0 (fi) Farmaseuttinen koostumus ja menetelmä sen valmistamiseksi
FI952324A0 (fi) Heterosykliset karbamaatit, menetelmä niiden valmistamiseksi ja lääkkeet
DK0635004T3 (da) 4-Diphenylmethylpiperidinderivater og fremgangsmåde til fremstilling deraf
ITMI932540A0 (it) Composizione farmaceutica
DK0735042T3 (da) Maltitolsammensætning og fremgangsmåde til fremstilling deraf
BR9509688A (pt) Composto e composição farmacêutica
IL117397A (en) Substituted naphthyl compounds and pharmaceutical compositions comprising them
EE9800164A (et) Farmatseutiline kompositsioon ja meetod epitelioomi raviks
FI941914A (fi) 2-amino-4-kinoliinidihydropyridiinejä, menetelmiä niiden valmistamiseksi ja niiden käyttö
FI942298A0 (fi) Menetelmä ja sovitelma tilaelementtien siirtämiseksi
FI960316A (fi) Oksatiolaanit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
FI955123A (fi) Kolestyramiinia sisältävä koostumus ja menetelmä tämän valmistamiseksi
FI940403A (fi) Elliptisiinijohdannainen ja menetelmä sen valmistamiseksi
LV10579A (lv) Farmaceitiska kompozicija
NO943826D0 (no) Heteroarylpiperidiner, fremgangsmåte for fremstilling og farmasöytiske blandinger hvor de er tilstede
BR9505130A (pt) Composto e composiçao farmacêutica

Legal Events

Date Code Title Description
FD Application lapsed